Simplify your prep

ReadyPrepTM Total Prep System

Request Samples
Two ReadyPrep Total Prep System pouches

Achieve consistent and effective pre-operative prep

ReadyPrep™ Total Prep System can help you overcome the challenges of pre-operative prep to deliver an antiseptic agent consistently, safely and effectively to the three main sources of bacteria—skin, nose and mouth.

ReadyPrep™ Total Prep System helps protect your patients from SSIs

This easy-to-use kit can help reduce Staphylococcus aureus (and other dangerous microbes) on the skin, in the nose and in the mouth to help reduce SSIs and shorten hospital stays.

Dark grey silhouette of a human figure with concentric, light grey circles in the background

*To be used for surgical skin site preparation.

For the nose and mouth:
Nasal and Oral Antiseptic Cleansing Kit

Antiseptic Nasal Swabs

Our ready-to-use nasal swabs, pre-saturated with 10% povidone-iodine or 62% ethyl alcohol, can help simplify application to decolonize the nose.

Clinical Oral Rinse Solutions

Applying 0.12% chlorhexidine gluconate (CHG) or 0.1% cetylpyridinium chloride (DuoCareTM) clinical oral rinses can help reduce the risk of infection.

ReadyPrep Nasal and Oral Antiseptic Cleansing Kits in PVP and ethyl alcohol versions
25%

Less total application time using Medline’s Antiseptic Nasal Swabs vs. competition.4

Icon

Reduction of Staphylococcus aureus inside the nose with Medline’s 62% Ethyl Alcohol Nasal Swabs.5

Icon

Povidone-iodine and 62% ethyl alcohol are well-tolerated, non irritation antiseptics3 for a positive patient experience.

80%

Percentage of SSIs are traced to patient’s own nasal bacteria DNA.6,7,8

For the skin:
ReadyPrep CHG — Pre-saturated 2% CHG Cloths

Effective CHG release

Single fiber technology in the 100% polyester cloth effectively and consistently releases CHG on the skin.

Moisture-retaining packaging

Cutting-edge film barrier with a low moisture vapor transition rate (MVTR) helps keep our cloths moist and viable for long periods of time.

Learn more about CHG Cloths
ReadyPrep CHG Packet with a CHG cloth
Icon

68% larger cloth9
ReadyPrep CHG cloths have a 94.5″ surface area, and measure 9″ x 10.5″.

Icon

Up to 6 hours
Reduces microorganisms on the skin for up to 6 hours after application.10

Icon

Rapid kill time
Kills Staphylococcus aureus and
other SSI-causing bacteria.11

Icon

Long shelf life
Two-year shelf life
can help you save money.12

Icon

500 mg of CHG
Each cloth contains 500 mg of CHG to help reduce bacteria that can cause SSIs.

We make it easy and convenient to reduce the risk of SSIs

ReadyPrep™ Total Prep System ordering information

For the skin, nose and mouth:

Item No. Description Pkg.
MDS1994 ReadyPrep Total Prep System – Skin, Nose and Mouth with 62% Ethyl Alcohol Nasal Swabs and 0.12% CHG oral rinse 20/cs
MDS1996 ReadyPrep Total Prep System – Skin, Nose and Mouth with 10% PVP Nasal Swabs and 0.12% CHG oral rinse 20/cs
MDS1998 ReadyPrep Total Prep System – Skin, Nose and Mouth with 62% Ethyl Alcohol Nasal Swabs and DuoCare™ clinical oral rinse 20/cs
ReadyPrep Total Prep System—Skin, Nose and Mouth

For the skin and nose:

Item No. Description Pkg.
MDS1993 ReadyPrep Total Prep System – Skin and Nose with 62% Ethyl Alcohol Nasal Swabs and DuoCare™ clinical oral rinse 20/cs
MDS1997 ReadyPrep Total Prep System – Skin and Nose with 10% PVP Nasal Swabs 20/cs
ReadyPrep Total Prep System—Skin and Nose

Request a sample and schedule a trial for the ReadyPrep Total Prep System

(For professional use only. Not for home use.)

Upon receipt, a Medline Representative will schedule a visit to present the ReadyPrep Total Prep System.

How can we help you?

Contact Us
Call Us Now

References:

  1. Houang ET et al. Absence of bacterial resistance to povidone iodine. Journal of Clinical Pathology. 1976;29(8):752-755.
  2. Lanker Klossner B et al. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Dermatology. 1997;195(Suppl2):10-13.
  3. Data on file.
  4. Based on a comparison of labeling application instructions of competitive product
  5. Data on file.
  6. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001–2002. J Infect Dis. 2006;193:172-179.
  7. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mup. to prevent postoperative Staphylococcus aureus infections. N Engl J Med.2002;346:1871-1877.
  8. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, deBaere GAJ, Kluytmans JAJW. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol.
    2000;21:319-323
  9. Compared to market leader
  10. In vivo testing on file
  11. In vitro testing on file.
  12. In vitro testing on file.